IL17A and myeloid sarcoma: Further, IL-17 and IL-22 secreted by Th17 cells dampen selectivity of the BBB via the interruption of endothelial tight junctions, further increasing the permeability to peripheral immune cells and triggering a cascade of destructive inflammation that determines neuronal and glial cell damage in people with MS [18].